The enantiomers (+) and (-)-2,2-difluorocitrate have been synthesized. Both are good inhibitors of ATP-citrate lyase, showing competitive inhibition against citrate, with Kis = 0.7 pM for (+)-2,2-difluorocitrate and 3.2 pM for (-)-2,2-difluorocitrate. The inhibition patterns with either ATP or CoA as the varied substrate were uncompetitive and mixed, respectively, but with much weaker inhibition constants. Neither isomer undergoes carbon-carbon bond cleavage as a substrate and there is no evidence of irreversible time-dependent inactivation. When ATP-citrate lyase is incubated with CoA and difluorocitrate, the maximal intrinsic ATPase rate is 10% of the citrate-induced rate for the (+)-enantiomer and 2% for the (-)-enantiomer. 19F-NMR studies confirm that only the (+)-enantiomer is chemically processed.The effects of the difluorocitrate enantiomers on the reaction catalysed by aconitase were examined. (-)-2,2-Difluorocitrate is a competitive inhibitor against citrate (Ki, = 1.5 pM), whereas the (+)-enantiomer is a relatively poor mixed inhibitor (Ki > 300 pM). The (-)-enantiomer irreversibly inactivates aconitase at 1.1 min-' . mM-' at 25°C and pH 7.4, whereas no irreversible inhibition is seen with the (+)-enantiomer. Therefore, it would be expected that the (+)-enantiomer would slow the rate of acetyl-CoA synthesis in vivo, without inhibiting the citric acid cycle.ATP-citrate lyase catalyses the production of cytosolic acetyl-CoA and oxaloacetate from citrate, with the concomitant hydrolysis of ATP to ADP and inorganic phosphate. The acetyl-CoA produced, plays a central role in mammalian fatty acid and cholesterol biosynthesis. In vivo dosing of hydroxycitrate, a potent inhibitor of ATP-citrate lyase reduces de m v o synthesis of fatty acids and cholesterol in the liver and adipose tissues (Sullivan et al., 1973). Inhibition of this enzyme would therefore be a useful strategy for treating hyperlipidaemia or hypercholes terolaemia.A mechanism has been proposed for the enzyme (Walsh, 1979; Wells, 1991) which involves enzyme phosphorylation, transfer of the phosphate to activate citrate, formation of a citryl-CoA intermediate and fragmentation of citryl-CoA to produce acetyl-CoA and oxaloacetate. The final step is a basecatalysed retro-Claisen reaction and will generate an incipient anion on the acetyl fragment. This allows several possibilities for the design of mechanism-based inhibitors of ATP-citrate lyase (Dolle et al., 1991). If the hydrogens on the nascent acetyl-CoA were replaced by fluorine, the incipient anion could have novel decay modes. For example, fluoride loss would generate a carbene within the active site. This could then attack groups within the active site, irreversibly inCurrespondenre to T. N.